APO-LAMIVUDINE-ZIDOVUDINE
APOTEX INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-LAMIVUDINE-ZIDOVUDINE in Canada?
A shortage of APO-LAMIVUDINE-ZIDOVUDINE 300MG 150MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated July 23, 2026), but it has not started yet.
Why is APO-LAMIVUDINE-ZIDOVUDINE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-LAMIVUDINE-ZIDOVUDINE be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02375540
Strength
300MG 150MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ZIDOVUDINE LAMIVUDINE
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178